DK0446143T3 - Affedtede polysaccharidderivater, fremgangsmåde til fremstilling heraf samt præparater indeholdende disse - Google Patents

Affedtede polysaccharidderivater, fremgangsmåde til fremstilling heraf samt præparater indeholdende disse

Info

Publication number
DK0446143T3
DK0446143T3 DK91400648.1T DK91400648T DK0446143T3 DK 0446143 T3 DK0446143 T3 DK 0446143T3 DK 91400648 T DK91400648 T DK 91400648T DK 0446143 T3 DK0446143 T3 DK 0446143T3
Authority
DK
Denmark
Prior art keywords
compound
degreased
processes
preparation
weight
Prior art date
Application number
DK91400648.1T
Other languages
Danish (da)
English (en)
Inventor
Hans Binz
Dhinterland Lucien Dussourd
Gerard Normier
Pape Alain Le
Michel Favaron
Souhail Delassan
Original Assignee
Pierre Fabre M Dicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre M Dicament filed Critical Pierre Fabre M Dicament
Application granted granted Critical
Publication of DK0446143T3 publication Critical patent/DK0446143T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK91400648.1T 1990-03-08 1991-03-08 Affedtede polysaccharidderivater, fremgangsmåde til fremstilling heraf samt præparater indeholdende disse DK0446143T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9002957A FR2659351B1 (fr) 1990-03-08 1990-03-08 Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.

Publications (1)

Publication Number Publication Date
DK0446143T3 true DK0446143T3 (da) 1995-03-13

Family

ID=9394527

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91400648.1T DK0446143T3 (da) 1990-03-08 1991-03-08 Affedtede polysaccharidderivater, fremgangsmåde til fremstilling heraf samt præparater indeholdende disse

Country Status (11)

Country Link
US (1) US5601799A (de)
EP (1) EP0446143B1 (de)
JP (1) JPH04220401A (de)
AT (1) ATE116662T1 (de)
AU (1) AU646842B2 (de)
CA (1) CA2037741A1 (de)
DE (1) DE69106406T2 (de)
DK (1) DK0446143T3 (de)
ES (1) ES2068527T3 (de)
FR (1) FR2659351B1 (de)
GR (1) GR3015538T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
US5406950A (en) * 1993-12-23 1995-04-18 Mallinckrodt Medical, Inc. Inhalable contrast agent
FR2717483B1 (fr) * 1994-03-16 1996-06-07 Pf Medicament Préparation d'un composé polysaccharidique D25 délipidé et purifié et composition injectable en comportant.
FR2734160B1 (fr) * 1995-05-18 1997-08-01 Pf Medicament Utilisation d'un compose comportant une structure glycanique pour le blocage d'anticorps et procede d'obtention d'un tel produit
CA2279147C (en) 1999-07-29 2003-02-18 Graminia Developments Ltd. Liquid for producing marker vapour, a method of producing marker vapour and a method of inspection with marker vapour
CA2438448C (en) * 2003-08-27 2008-11-18 Quality Fabricating & Machining Ltd. Leak detector
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
RU2401839C2 (ru) 2006-02-14 2010-10-20 Кусиро Индастриал Текнолоджи Сентер Способ получения протеогликана
JP6688498B2 (ja) * 2014-10-16 2020-04-28 地方独立行政法人青森県産業技術センター プロテオグリカンの分解方法及び分解物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285936A (en) * 1979-12-10 1981-08-25 The United States Of America As Represented By The Secretary Of The Army Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
DE3224788A1 (de) * 1981-07-17 1983-02-03 South African Inventions Development Corp., Scientia, Pretoria,Transvaal Traegergebundenes immunogenes material
US4873088A (en) * 1983-09-06 1989-10-10 Liposome Technology, Inc. Liposome drug delivery method and composition
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
FR2614306B1 (fr) * 1987-04-22 1989-07-28 Pf Medicament Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
FR2650506B1 (fr) * 1989-07-11 1991-11-08 Roussel Uclaf Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament

Also Published As

Publication number Publication date
ATE116662T1 (de) 1995-01-15
US5601799A (en) 1997-02-11
EP0446143B1 (de) 1995-01-04
CA2037741A1 (fr) 1991-09-09
EP0446143A2 (de) 1991-09-11
FR2659351A1 (fr) 1991-09-13
JPH04220401A (ja) 1992-08-11
EP0446143A3 (en) 1992-02-12
ES2068527T3 (es) 1995-04-16
FR2659351B1 (fr) 1994-12-02
DE69106406D1 (de) 1995-02-16
GR3015538T3 (en) 1995-06-30
AU7263791A (en) 1991-09-12
DE69106406T2 (de) 1995-05-24
AU646842B2 (en) 1994-03-10

Similar Documents

Publication Publication Date Title
NO161573C (no) Fremgangsmaate til fremstilling av hyaluronsyre.
ATE110531T1 (de) Hochsaures system enthaltende nahrungsformulierungen.
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
FI884698A0 (fi) Bis-aldonamider samt foerfarande foer framstaellning av desamma.
DK0444891T3 (da) Fødevarebestanddel med den funktion at forbedre serumlipid
HU913887D0 (en) Pharmaceutical preparatives
DE69434356D1 (de) Inclusion-Komplex von Beta-Cyclodextrin mit Diclofenac
FR2659351B1 (fr) Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.
ES2119161T3 (es) Soluciones de dialisis peritoneal mejoradas que incluyen polipeptidos.
EP0143393A3 (de) Verwendung ultrareiner Hyaluronsäure zur Verbesserung der Funktion von tierischen Gelenken
ATE162188T1 (de) Herstellung von derivaten von n-acetyl neuraminicsäure
CA2047802A1 (en) Pharmaceutical compositions
SE8800989L (sv) Dietkomposition samt foerfarande foer framstaellning av densamma
SE8800988L (sv) Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
ATE125270T1 (de) Tert-butyloxycarbonyl-l-tyrosyl- peptidoglycanmonomer und deren 125 i-markiertes derivat, deren herstellung und verwendung.
DE69422151D1 (de) Pulverförmiges nahrungsmittel und herstellung desselben
DE3672387D1 (de) Herstellung von zelladhaesioninhibitoren, so erhaltene antiadhaesine und diese enthaltende arzneimittel und naehrmittel.
FR2583756B1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation
FR2572080B1 (fr) Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
IT213651Z2 (it) Sistema di allungamento cosmarper tavoli d'arredamento.
KR880006359A (ko) 사람의 tiits를 제조하기 위한 중간물질로서의 균일한 양 tiits 및 이의 용도
IT220902Z2 (it) Sistema di mobili componibili a piu' categorie di componenti spaziali.
IT8983421A0 (it) Sistema di giunzione particolarmente idoneo per l'assemblaggio di tavoli.
IT221067Z2 (it) Sistema di smontabilita' e reclinabilita' idoneo per mobili per sedersi
IT7822269V0 (it) Elementi componibili per la realizzazione di mobili, in particolare di armadi, scaffalature nonche' mobili da cucina.